Valeurs

Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.

Show advanced options

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Nom	Code	Analysis date	Cours de clôture	+/- %
John Hancock Investors Trust	JHI	28. mar 2025	13.56	-0.22
John Hancock Pfd Income Fund II	HPF	28. mar 2025	16.71	+0.12
John Hancock Preferred Income Fund	HPI	28. mar 2025	16.63	+0.61
John Hancock Preferred Income Fund III	HPS	28. mar 2025	15.06	+0.33
John Hancock Premium Dividend Fund	PDT	28. mar 2025	12.99	+0.54
John Hancock Tax Advantaged Dividend Fund	HTD	28. mar 2025	23.77	+1.19
John Marshall Bancorp	JMSB	28. mar 2025	17.12	-0.93
John Wiley & Sons A	WLY	28. mar 2025	44.41	-0.91
John Wiley & Sons B	WLYB	28. mar 2025	44.80	0.00
Johnson & Johnson	JNJ	28. mar 2025	163.71	+0.36
Johnson Controls International	JCI	28. mar 2025	79.69	-3.02
Johnson Outdoors A	JOUT	28. mar 2025	24.91	-3.56
Joint Stock Company Kaspi.kz	KSPI	28. mar 2025	94.04	+1.33
Jones Lang LaSalle	JLL	28. mar 2025	245.90	-1.84
Journey Medical	DERM	28. mar 2025	6.11	+3.21
Jowell Global	JWEL	28. mar 2025	2.06	-9.65
JOYY ADR	YY	28. mar 2025	41.55	-2.53
JP Morgan Chase	JPM	28. mar 2025	242.85	-2.12
JP Morgan Chase & Co EE Pref	JPM-C	28. mar 2025	25.18	-0.04
JP Morgan Chase & Co GG Pref	JPM-J	28. mar 2025	20.71	-0.29
JP Morgan Chase & Co Ser DD Pref	JPM-D	28. mar 2025	24.83	-0.20
JPMorgan Nasdaq Equity Premium Income ETF	JEPQ	28. mar 2025	51.81	-2.21
Jumia Technologies ADR	JMIA	28. mar 2025	2.24	-4.27
Junee Limited - Ordinary Shares	JUNE	28. mar 2025	9.46	+7.43
Junior Gold Miners ETF Market Vectors	GDXJ	28. mar 2025	56.85	-1.06
Juniper Networks	JNPR	28. mar 2025	36.12	-0.08
Jupiter Neurosciences	JUNS	28. mar 2025	0.70	-5.76
JVSPAC Acquisition	JVSAU	28. mar 2025	11.10	0.00
JVSPAC Acquisition	JVSA	28. mar 2025	10.72	0.00
JX Luxventure	JXG	28. mar 2025	2.52	0.00

Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.